SYMZIBEL Trademark

Trademark Overview

On Tuesday, October 25, 2016, a trademark application was filed for SYMZIBEL with the United States Patent and Trademark Office. The USPTO has given the SYMZIBEL trademark a serial number of 87214222. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, April 7, 2020. This trademark is owned by Vertex Pharmaceuticals Incorporated. The SYMZIBEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
symzibel

General Information

Serial Number87214222
Word MarkSYMZIBEL
Filing DateTuesday, October 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, April 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 5, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2019EXTENSION 5 GRANTED
Tuesday, October 1, 2019EXTENSION 5 FILED
Friday, October 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 1, 2019TEAS EXTENSION RECEIVED
Friday, July 5, 2019ASSIGNED TO EXAMINER
Saturday, March 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019EXTENSION 4 GRANTED
Thursday, March 28, 2019EXTENSION 4 FILED
Thursday, March 28, 2019TEAS EXTENSION RECEIVED
Thursday, October 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 2, 2018EXTENSION 3 GRANTED
Tuesday, October 2, 2018EXTENSION 3 FILED
Tuesday, October 2, 2018TEAS EXTENSION RECEIVED
Thursday, April 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 3, 2018EXTENSION 2 GRANTED
Tuesday, April 3, 2018EXTENSION 2 FILED
Tuesday, April 3, 2018TEAS EXTENSION RECEIVED
Thursday, October 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2017EXTENSION 1 GRANTED
Tuesday, October 3, 2017EXTENSION 1 FILED
Tuesday, October 3, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2017ASSIGNED TO EXAMINER
Friday, October 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 28, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

symzibel fibrosis cystic treatment preparations pharmaceutical